Overview
- 4 inspections across 4 sites are on record.
- 3 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-20.
At a glance
Inspections
4
Sites
4
Observations
3
Career since
Jul 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| The Harvard Drug Group LLC | 20 Mar 2026 | Human Drugs | View 483 → |
| VET4U, LLC | 11 Mar 2026 | Human Drugs | On file |
| Sterling Distributors | 6 Mar 2025 | Human Drugs | On file |
| Valisure, LLC | 6 Jul 2021 | Human Drugs | On file |
Sites inspected
The Harvard Drug Group LLCLa Vergne, United States1 insp.
VET4U, LLCClay, United States1 insp.
Sterling DistributorsCoral Springs, United States1 insp.
Valisure, LLCNew Haven, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Nelson N Ayangho1 shared
Armen H Youssoufian1 shared
Ogechi C Nna1 shared
Demario L Walls1 shared
Jose F Velez1 shared
Jonah S Ufferfilge1 shared
Robert J Martin1 shared
Full investigator report
Get the verbatim findings behind Sarah E Venti's 3 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site